Literature DB >> 8694820

Interaction of RGD liposomes with platelets.

T Nishiya1, S Sloan.   

Abstract

The interactions of platelets and liposomes with the tripeptide arginine-glycine-aspartic acid (RGD) as a surface ligand (RGD liposomes) were studied. The results suggest that the presence of the RGD ligand on the liposomes results in receptor-mediated mixing of lipid and aqueous contents of the liposomes and platelets. Mixing of the lipid and aqueous contents of RGD liposomes with platelets is approximately 4-9 times and 3-4 times greater than that for unlabeled liposomes, respectively. Measurements of the cytoplasmic free Ca2+ concentration in platelets, [Ca2+]i, show that the RGD liposomes have little effect on [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694820     DOI: 10.1006/bbrc.1996.1014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.

Authors:  Guofeng Huang; Zhongmin Zhou; Rekha Srinivasan; Marc S Penn; Kandice Kottke-Marchant; Roger E Marchant; Anirban S Gupta
Journal:  Biomaterials       Date:  2008-01-14       Impact factor: 12.479

Review 2.  Nanoparticles and the blood coagulation system. Part II: safety concerns.

Authors:  Anna N Ilinskaya; Marina A Dobrovolskaia
Journal:  Nanomedicine (Lond)       Date:  2013-06       Impact factor: 5.307

3.  In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.

Authors:  Rekha Srinivasan; Roger E Marchant; Anirban Sen Gupta
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.